Axsome Therapeutics, Inc. (NASDAQ:AXSM) Receives $105.50 Consensus Price Target from Analysts
Axsome Therapeutics, Inc. (NASDAQ:AXSM – Get Free Report) has earned an average recommendation of “Moderate Buy” from the ten analysts that are covering the stock, MarketBeat Ratings reports. Two research analysts have rated the stock with a hold recommendation and eight have assigned a buy recommendation to the company. The average twelve-month price target among […]
More Stories
Critical Comparison: Solaris Energy Infrastructure (NASDAQ:SEI) versus Drilling Tools International (NASDAQ:DTI)
Drilling Tools International (NASDAQ:DTI – Get Free Report) and Solaris Energy Infrastructure (NASDAQ:SEI – Get Free Report) are both small-cap...
The Role of Analytics in Online Radio Station Software
In today’s technology-driven era, where the digital landscape transforms how people interact with media content, radio stations have become a...
EOR or In-House HR to Handle Global Employment?
Venturing into global markets is an exciting yet challenging prospect for many businesses. Strategic HR decisions can help hugely influence...
Veracyte, Inc. (NASDAQ:VCYT) Receives Average Rating of “Moderate Buy” from Brokerages
Shares of Veracyte, Inc. (NASDAQ:VCYT – Get Free Report) have received an average recommendation of “Moderate Buy” from the nine...
Dyne Therapeutics, Inc. (NASDAQ:DYN) Given Consensus Recommendation of “Buy” by Analysts
Shares of Dyne Therapeutics, Inc. (NASDAQ:DYN – Get Free Report) have earned an average rating of “Buy” from the thirteen...
APi Group Co. (NYSE:APG) Receives Consensus Rating of “Moderate Buy” from Brokerages
Shares of APi Group Co. (NYSE:APG – Get Free Report) have been given a consensus rating of “Moderate Buy” by...